TLR4 and coronary artery disorder: In summary, our present study demonstrated that the decreased RFX1 expression in CD14+ monocytes contributed to the overexpression and the aberrant epigenetic modifications of TLR4 genes, leading to the activation of monocytes in CAD patients.